SYNTHETIC VECTOR DESIGNS, LLC

St. Louis, MO · Biotech · Private

Engineered bacterial transposase variants and vectors for precise, large DNA insertion into prokaryotic and eukaryotic chromosomes

syntheticvectordesigns.com →
Grants
$295K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I:Directed evolution of site-specific bacterial transposase genes to alter specificity and efficiency of insertion of large DNA segments into restorable gene fusions$294,999
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2428SOLLUS THERAPEUTICS, INC.——
2429Advanced Vision Technologies, Inc.——
2430STELLULAR BIO, INC.——
2431SYNTHETIC VECTOR DESIGNS, LLC——
2432GLSYNTHESIS, INC.——
2433PRAXIS BIORESEARCH, LLC——
2434Coactigon, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.